These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9195269)

  • 1. Albendazole treatment and serological follow-up in hydatid disease of bone.
    Bonifacino R; Dogliani E; Craig PS
    Int Orthop; 1997; 21(2):127-32. PubMed ID: 9195269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalized management of patients with inoperable alveolar echinococcosis undergoing treatment with albendazole: usefulness of positron-emission-tomography combined with serological and computed tomography follow-up.
    Crouzet J; Grenouillet F; Delabrousse E; Blagosklonov O; Thevenot T; Di Martino V; Piarroux R; Mantion GA; Bresson-Hadni S
    Clin Microbiol Infect; 2010 Jun; 16(6):788-91. PubMed ID: 19912267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the immunological surveillance value of humoral and lymphocyte assays in severe human cystic echinococcosis.
    Bonifacino R; Carter SD; Craig PS; Almeida I; Da Rosa D
    Trans R Soc Trop Med Hyg; 2000; 94(1):97-102. PubMed ID: 10748912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albendazole therapy for a recurrent orbital hydatid cyst.
    Sihota R; Sharma T
    Indian J Ophthalmol; 2000 Jun; 48(2):142-3. PubMed ID: 11116513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody responses of patients with cystic hydatid disease to recombinant myophilin of Echinococcus granulosus.
    Martin RM; Colebrook AL; Gasser RB; Lightowlers MW
    Acta Trop; 1996 Aug; 61(4):307-14. PubMed ID: 8910655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune status during albendazole therapy for hydatidosis.
    Matossian RM; Awar GN; Radwan H; Craig PS; Meshefedjian GA
    Ann Trop Med Parasitol; 1992 Feb; 86(1):67-75. PubMed ID: 1616397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological monitoring of progression of alveolar echinococcosis with multiorgan involvement by use of recombinant Em18.
    Ishikawa Y; Sako Y; Itoh S; Ohtake T; Kohgo Y; Matsuno T; Ohsaki Y; Miyokawa N; Nakao M; Nakaya K; Ito A
    J Clin Microbiol; 2009 Oct; 47(10):3191-6. PubMed ID: 19656973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial characterization of antigens in circulating immune complexes in cystic hydatid patients treated with albendazole.
    Bonifacino R; Craig P; Carter S; Malgor R; Dixon J
    Trans R Soc Trop Med Hyg; 1993; 87(1):97-102. PubMed ID: 8465413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A medically treated multiple cerebral hydatid cyst disease.
    Altas M; Aras M; Serarslan Y; Davran R; Evirgen O; Yilmaz N
    J Neurosurg Sci; 2010 Jun; 54(2):79-82. PubMed ID: 21313960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary peritoneal echinococcosis causing massive bilateral hydronephrosis and renal failure.
    Lissandrin R; Agliata S; Brunetti E
    Int J Infect Dis; 2013 Feb; 17(2):e141-2. PubMed ID: 23218548
    [No Abstract]   [Full Text] [Related]  

  • 11. Orbital hydatid cyst: treatment and prevention of recurrences with albendazole plus praziquantel.
    Jimenénez-Mejías ME; Alarcón-Cruz JC; Márquez-Rivas FJ; Palomino-Nicás J; Montero JM; Pachón J
    J Infect; 2000 Jul; 41(1):105-7. PubMed ID: 11041707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Albendazole treatment of cerebral hydatid disease: evaluation of results with CT and MRI.
    Kalaitzoglou I; Drevelengas A; Petridis A; Palladas P
    Neuroradiology; 1998 Jan; 40(1):36-9. PubMed ID: 9493186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serology in patients treated with albendazole for hydatid disease.
    Wilcox MH; Morris DL; Bailey JW
    J R Soc Med; 1988 Dec; 81(12):714-7. PubMed ID: 3221367
    [No Abstract]   [Full Text] [Related]  

  • 14. A placebo controlled study of albendazole in the treatment of pulmonary echinococcosis.
    Keshmiri M; Baharvahdat H; Fattahi SH; Davachi B; Dabiri RH; Baradaran H; Ghiasi T; Rajabimashhadi MT; Rajabzadeh F
    Eur Respir J; 1999 Sep; 14(3):503-7. PubMed ID: 10543267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complications of albendazole treatment in hydatid disease of lung.
    Kurkcuoglu IC; Eroglu A; Karaoglanoglu N; Polat P
    Eur J Cardiothorac Surg; 2002 Oct; 22(4):649-50. PubMed ID: 12297195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy of Echinococcus infection in man with albendazole.
    Horton RJ
    Trans R Soc Trop Med Hyg; 1989; 83(1):97-102. PubMed ID: 2603216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe disseminated hydatid disease successfully treated medically with prolonged administration of albendazole.
    Ntusi NA; Horsfall C
    QJM; 2008 Sep; 101(9):745-6. PubMed ID: 18448474
    [No Abstract]   [Full Text] [Related]  

  • 18. Bone hydatid disease refractory to nitazoxanide treatment.
    Schipper HG; Simsek S; van Agtmael MA; van Lienden KP
    Am J Trop Med Hyg; 2009 Sep; 81(3):446-8. PubMed ID: 19706912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Albendazole--objective evidence of response in human hydatid disease.
    Morris DL; Dykes PW; Marriner S; Bogan J; Burrows F; Skeene-Smith H; Clarkson MJ
    JAMA; 1985 Apr; 253(14):2053-7. PubMed ID: 3883020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albendazole as a potential treatment for human hydatidosis.
    Saimot AG; Meulemans A; Cremieux AC; Giovanangeli MD; Hay JM; Delaitre B; Coulaud JP
    Lancet; 1983 Sep; 2(8351):652-6. PubMed ID: 6136799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.